Business Briefing: Pfizer to Apply for Breast Cancer Drug Approval

Saturday, May 17, 2014 - 05:50 in Health & Medicine

The company said it would apply for approval to use palbociclib with a drug called Femara, or letrozole, as an initial treatment for postmenopausal women with a certain type of advanced breast cancer.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net